Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,942 | 2,933 | 5,916 | 2,362 | 1,526 |
| Marketable Securities | N/A | 1,241 | 2,329 | N/A | N/A |
| Other current assets | 0 | 103 | 1,064 | 877 | 432 |
| TOTAL | $6,617 | $5,192 | $9,309 | $3,239 | $1,959 |
| Non-Current Assets | |||||
| PPE Net | 83 | 89 | 99 | 118 | 112 |
| Other Non-Current Assets | 324 | 343 | 349 | 369 | 387 |
| TOTAL | $406 | $431 | $448 | $486 | $500 |
| Total Assets | $7,024 | $5,624 | $9,756 | $3,725 | $2,458 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,503 | 3,727 | 3,830 | 3,530 | 3,521 |
| Accrued Expenses | 49 | 44 | 39 | 35 | 32 |
| TOTAL | $4,552 | $3,770 | $3,869 | $3,564 | $13,553 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 29,326 | 24,268 | 23,419 | 14,760 | 9,228 |
| TOTAL | $29,326 | $24,268 | $23,419 | $14,760 | $9,228 |
| Total Liabilities | $33,878 | $28,038 | $27,287 | $18,324 | $22,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4 | 4 | 4 | 4 | 3 |
| Common Shares | 208 | 208 | 207 | 207 | 167 |
| Retained earnings | -168,378 | -163,052 | -157,613 | -152,877 | -147,585 |
| Other shareholders' equity | 0 | 9 | 4 | 0 | 0 |
| TOTAL | $-26,854 | $-22,415 | $-17,531 | $-14,599 | $-20,323 |
| Total Liabilities And Equity | $7,024 | $5,624 | $9,756 | $3,725 | $2,458 |